CALIX, INC. Insider Trading Activity

Insider Trade Summary

Exercise and Sale: 200,000 shares ($9.90M approx. pre-tax spread)

Exercise and Sale 9 txns

Insider Weening Michael

Role President & CEO

Sold 200,000 shs ($11.12M)

Approx. gross sale proceeds $11.12M

Approx. exercise cost $1.22M

Approx. pre-tax spread $9.90M

Type	Security	Shares	Price	Value
Exercise	Stock Option (right to buy)	92,000	$0.00	$0.00
Exercise	Stock Option (right to buy)	16,000	$0.00	$0.00
Exercise	Common Stock	92,000	$5.95	$547K
Sale	Common Stock	92,000	$56.00	$5.15M
Exercise	Common Stock	16,000	$8.03	$128K
Sale	Common Stock	16,000	$57.00	$912K
Exercise	Stock Option (right to buy)	92,000	$0.00	$0.00
Exercise	Common Stock	92,000	$5.95	$547K
Sale	Common Stock	92,000	$55.00	$5.06M

Holdings After Transaction: Stock Option (right to buy) — 74,000 contracts (Direct); Common Stock — 15,812 shares (Direct)

Footnotes (2)

1. F1. 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021.
2. F2. 100% of the shares subject to the option were fully vested and exercisable on February 14, 2023.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/24/2025 - 06:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Weening Michael

(Last) (First) (Middle)

C/O CALIX, INC.

2777 ORCHARD PARKWAY

(Street)

SAN JOSE CA 95134

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CALIX, INC [ (CALX) ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/22/2025		M		92,000	A	$5.95	107,812	D
Common Stock	07/22/2025		S		92,000	D	$55	15,812	D
Common Stock	07/23/2025		M		92,000	A	$5.95	107,812	D
Common Stock	07/23/2025		S		92,000	D	$56	15,812	D
Common Stock	07/23/2025		M		16,000	A	$8.03	31,812	D
Common Stock	07/23/2025		S		16,000	D	$57	15,812	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$5.95	07/22/2025		M			92,000	(1)	12/29/2027	Common Stock	92,000	$0	92,000	D
Stock Option (right to buy)	$5.95	07/23/2025		M			92,000	(1)	12/29/2027	Common Stock	92,000	$0	0	D
Stock Option (right to buy)	$8.03	07/23/2025		M			16,000	(2)	02/14/2029	Common Stock	16,000	$0	74,000	D

Explanation of Responses:

1. 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021.

2. 100% of the shares subject to the option were fully vested and exercisable on February 14, 2023.

Remarks:

Sales reported on the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.

	/s/ Tom Gemetti as Attorney-in-Fact for Michael Weening	07/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.